secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001493152-24-025435
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience announces 1-for-12 reverse stock split effective July 1, 2024 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- 1-for-12 reverse stock split effective July 1, 2024; shares reduce from ~101.1M to ~8.4M.
- Purpose: regain compliance with Nasdaq $1.00 minimum bid price requirement.
- Stockholder authorization obtained at June 5, 2024 annual meeting; Board set ratio at 1-for-12.
- No fractional shares issued; fractional interests rounded up to next whole share after aggregation.
- New CUSIP 23666P200; stock continues trading as DARE on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/0001493152-24-025435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224025435/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer